BD PharmingenTM PE-CyTM5 Mouse Anti-Human HLA-DR

Description

Flow cytometric analysis of HLA-DR on human peripheral blood lymphocytes. Human whole blood was lysed with BD FACS Lysing Solution Cat. No. 349202 and stained with PE-Cy5 Mouse IgG2a, kappa Isotype Control Cat. No. 555575; dashed line histogram or with PE-Cy5 Mouse Anti-Human HLA-DR Cat. No. 555813/562007; solid line histogram . Fluorescent histograms showing expression of HLA-DR or Ig isotype staining were derived from gated events based on forward and side light scattering characteristics for intact lymphocytes. Flow cytometric analysis was performed on a BD FACScan system. Flow cytometric analysis of HLA-DR on human peripheral blood lymphocytes. Human whole blood was lysed with BD FACS Lysing Solution Cat. No. 349202 and stained with PE-Cy5 Mouse IgG2a, kappa Isotype Control Cat. No. 555575; dashed line histogram or with PE-Cy5 Mouse Anti-Human HLA-DR Cat. No. 555813/562007; solid line histogram . Fluorescent histograms showing expression of HLA-DR or Ig isotype staining were derived from gated events based on forward and side light scattering characteristics for intact lymphocytes. Flow cytometric analysis was performed on a BD FACScan system. Show More Flow cytometric analysis of HLA-DR on human peripheral blood lymphocytes. Human whole blood was lysed with BD FACS Lysing Solution Cat. No. 349202 and stained with PE-Cy5 Mouse IgG2a, kappa Isotype Control Cat. No. 555575; dashed line histogram or with PE-Cy5 Mouse Anti-Human HLA-DR Cat. No. 555813/562007; solid line histogram . Fluorescent histograms showing expression of HLA-DR or Ig isotype staining were derived from gated events based on forward and side light scattering characteristics for intact lymphocytes. Flow cytometric analysis was performed on a BD FACScan system.